company

NORSK ONKOLOGISK FORENING

2069 JESSHEIM

Return on Equity
17,79 %
Current Ratio
18,73
Debt-to-Equity Ratio
0
Key figures (NOK)2009
Revenue356 000
Net Income142 000
Total Assets843 000
Total Equity798 000
Income (NOK)2009
Revenue356 000
Expenditure214 000
Operating Profit142 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax142 000
Tax0
Net Income142 000
Balance (NOK)2009
Total Fixed Assets0
Total Current Assets843 000
Total Assets843 000
Total Retained Equity798 000
Total Equity798 000
Total Long-Term Debt0
Total Current Debt45 000
Total Equity and Debt843 000
Cash flow (NOK)2009
Sales Income355 000
Other Income1 000
Revenue356 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure214 000
Operating Profit142 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income142 000
Balance details (NOK)2009
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank746 000
Total Current Assets843 000
Total Assets843 000
Total Equity798 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors45 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt45 000
Total Equity and Debt843 000
Financial indicators2009
Return on Equity17,79 %
Debt-to-Equity Ratio0
Operating Profit Margin39,89 %
Current Ratio18,73
Quick Ratio18,73
Equity Ratio0,95
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English